| Value | ₹6.53 Cr |
|---|
NSE filing, NSE: AUROPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Aurobindo Pharma Ltd: key numbers
- Share price
- ₹1,800.00
- Market cap
- ₹1,04,544 Cr
- Revenue (annual)
- ₹33,653 Cr
- Net profit (annual)
- ₹3,505 Cr
- P/E (TTM)
- 24.8×Sector 43.0×
- Promoter holding
- 51.88%+0.00% QoQ
- FII holding
- 17.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aurobindo Pharma Ltd
All →Aurobindo Pharma Acquisition Worth ₹29 Cr
Aurobindo's subsidiary Auropharm Overseas will buy 100% of Auro Pharma LLC, a Russian step-down subsidiary, for about Rs 29 crore cash. It is an internal group reorganisation.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Aurobindo Pharma Management Change
Aurobindo Pharma's board approved reappointing independent director Mangalam Ramasubramanian Kumar for a second five-year term from April 1, 2027. Shareholder approval by postal ballot is required.
- Execution
- Five years from April 1, 2027
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Aurobindo Pharma Acquisition
Aurobindo Pharma announced a board-approved proposal to merge two wholly owned subsidiaries, Auroactive Pharma into Apitoria Pharma, via NCLT scheme. No cash consideration; the share-exchange ratio issues 23,95,900 shares of Apitoria.
Aurobindo Pharma Dividend
Aurobindo Pharma declared an interim dividend of Rs 7.00 per share for FY27. Record date is 11 November 2026, with payment on or before 20 November.
Aurobindo Pharma Investor Presentation: Key Takeaways
Q2FY27 revenue ₹10,263 Cr (+23.9% YoY), record EBITDA ₹2,156 Cr at 21.0% margin, PAT ₹1,124 Cr (+32.5% YoY). Lannett acquisition completed.
Other legal & regulatory announcements
All →Tata Power Company Legal & Regulatory
Tata Power discloses Singapore court developments in its Kleros arbitration, including share attachment notices to two subsidiaries. Detailed appeal submissions are due November 23, 2026.
Baroda Rayon Corporation Legal & Regulatory
Baroda Rayon's ITAT Mumbai allowed both its quantum and penalty appeals for AY 2014-15, deleting a ₹12.15 Crore Section 68 addition and a ₹4.13 Crore penalty. The filing updates a pending tax litigation disclosed earlier.
- Value
- ₹12.15 Cr
HD Fire Protect Legal & Regulatory
HD Fire Protect received a GST order dropping a ₹7.10 Crore show-cause demand for FY 2022-23. The order has no financial or operational impact on the company.
- Value
- ₹7.10 Cr
EKI Energy Services Legal & Regulatory
EKI Energy's counterparty Vitol terminated an emission reduction agreement and invoked a USD 10 million bank guarantee. The company disputes the default claim and plans arbitration.
- Value
- ₹94.00 Cr
Mangalore Refinery And Petrochemicals Legal & Regulatory
MRPL received a Customs order demanding ₹1,39,871 plus interest and penalty for 2021 tariff misclassification. The company is considering challenging the order after depositing the money.
- Value
- ₹0.01 Cr
Alfa Ica (India) Legal & Regulatory
Alfa Ica India's board noted a ₹9,440 BSE fine for late Annual Report filing under Regulation 34. The penalty was remitted and stronger compliance tracking was advised.
- Value
- ₹0.00 Cr